FDA Investigator Rosa J Motta
Rosa J Motta has inspections in 7 countries as of 22 Sep 2023. Rosa J Motta has collaborated with a combined 853 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Malta,
Spain,
United States of America,
Italy,
Sweden,
France,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Adalberto Cajigas,
Alicia M Mozzachio,
Anita R Michael,
Ariel Cruz Figueroa,
Arlene M Badillo,
Cassandra L Abellard,
CDR Ileana Barreto Pettit,
Cody D Rickman,
Diane Kelley,
Erika V Butler,
German Rivera,
Helen B Ricalde,
Heriberto Negron Rivera,
Javier E Santos,
Jorge L Guadalupe,
Jorge L Lajara,
Jose E Melendez, DDC,
Kristy A Zielny,
Laurie B Frazier,
Leonard H Lavi,
Libia M Lugo,
Marian E Ramirez,
Marianela Aponte Cruz,
Maridalia Torres,
Maridalia Torres Irizarry,
Marybet Lopez,
Marybet Lopez Negron,
Matthew B Casale,
Matthew R Dionne,
Mra Mcculloughj,
Pal S Mayasandra,
Parul M Patel,
Patrick L Wisor,
Rajiv R Srivastava,
Ramon A Hernandez,
Raphael E Brykman,
Rebecca Parrilla,
Rebecca Rodriguez,
Richard J Friedman,
Rose J Motta,
Simone E Pitts,
Steven B Barber,
Steven D Kehoe,
Susan D Yuscius,
Victor J Gangi,
William D Tingley,
Youmin Wang
Rosa J Motta's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2003 | FDA 483 | Dipharma Francis S.r.l. - Form 483, 2003-06-19 |
October, 2010 | FDA 483 | Synthon Hispania S.L. - Form 483, 2010-10-01 |
June, 2003 | EIR | Quimica Sintetica S.A. - EIR, 2003-10-16 |
June, 2003 | FDA 483 | Quimica Sintetica S.A. - Form 483, 2003-06-26 |
September, 2008 | FDA 483 | Teva Puerto Rico LLC - Form 483, 2008-09-15 |
February, 2017 | EIR | Mipharm S.p.A. - EIR, 2017-02-03 |
June, 2003 | FDA 483 Response | Quimica Sintetica S.A. - Form 483R, 2003-06-26 |
February, 2017 | FDA 483 | Mipharm S.p.A. - Form 483, 2017-02-03 |
October, 2010 | EIR | Synthon Hispania S.L. - EIR, 2010-10-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more